An Experimental Drug Reverses Paralysis and Vision Loss in an MS Animal Model
An experimental drug has produced promising results in animal models of multiple sclerosis, raising the possibility that future MS treatments...
Read moreDetailsAn experimental drug has produced promising results in animal models of multiple sclerosis, raising the possibility that future MS treatments...
Read moreDetailsSemaglutide is best known as a GLP-1 medicine used to treat diabetes and obesity, but researchers are beginning to investigate...
Read moreDetailsArtificial intelligence may eventually transform medicine in a place that receives far less public attention than AI chatbots: the scientific...
Read moreDetailsBiomedical research has relied heavily on laboratory animals for decades, but scientists are developing increasingly sophisticated alternatives based directly on...
Read moreDetailsScientists have developed a miniature laboratory system that reproduces important aspects of one of the human body's most complex biological...
Read moreDetailsAmazon's warehouses are steadily evolving from facilities containing isolated robots into environments where autonomous machines can work much more closely...
Read moreDetailsPaid subscriptions and a new push into small-business tools are opening commercial opportunities for Muse, though early enthusiasm has yet...
Read moreDetailsThe artificial-intelligence boom is changing what it means to design a processor. Nvidia's Blackwell family is no longer best understood...
Read moreDetailsGlobal PR News is a newswire distributing press releases and company announcements across business, technology, science, health, and world news.
Privacy Policy | © 2026 Global PR News. All rights reserved.